Yes, drug R&D is difficult, costly and risky. But these factors don’t really justify a high price. Value does.
Subscribe to:
Post Comments (Atom)
< + > Is AI Headed for a Blockchain-Style Letdown? CVS Health’s Tilak Mandadi Doesn’t Think So
Healthcare keeps chasing its next big breakthrough. Right now, that spotlight is firmly on AI – touted as the industry’s next big thing. But...
No comments:
Post a Comment